Clinical trial Recruiting at 1 site Observational Men only

Correlation between PLC zeta measurements and semen parameters in male infertility

Official title: Assessing the Correlation Between Phospholipase C Zeta (PLCZeta) Measurements and Semen Parameters

Run by Fakih IVF Fertility Center · NCT07684339 · Data updated 2026-11-12

This study tests whether levels of the sperm protein PLCζ in semen relate to standard semen quality measures in men facing infertility.

More Male Infertility trials

Quick facts

Study typeObservational
SexMen only
Enrollment200 (estimated)
SponsorFakih IVF Fertility Center
Academic / other
Drugs / interventionschemotherapy, radiation
Locations2 sites (Abu Dhabi and 1 other locations)
StatusRecruiting
StartedJuly 1, 2026
Main results expectedJuly 1, 2027
Study endsAugust 2027
Registry record updatedJuly 6, 2026
Trial IDNCT07684339 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are couples seeking fertility treatment who have a total sperm count of at least 1 million per mL and have leftover sperm available after clinical procedures.

Probably not a fit

Patients with normal PLCζ function or those whose fertility challenges are unrelated to PLCζ may not experience direct benefit from this observational analysis.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational cohort study examines the relationship between phospholipase C zeta (PLCζ) measurements in semen and common semen parameters in men with infertility. Participants are couples pursuing IVF/ICSI or routine semen analysis, with leftover sperm available for testing. No intervention is administered beyond standard clinical care, and treatment outcomes from routine procedures are collected for analysis. The goal is to see if PLCζ levels could explain variability in fertilization potential and embryo development. The study is conducted at Fakih IVF Fertility Center in Abu Dhabi with collaboration from Khalifa University for Science and Technology.

Why it matters

Potential benefit: If PLCζ measurements correlate with semen quality, this could help personalize fertility treatments and identify couples who may benefit from specific activation or assisted techniques.

How similar studies have gone: Previous research has suggested PLCζ plays a role in oocyte activation, but the clinical utility of measuring PLCζ for predicting ART outcomes remains an area of active investigation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Couple inclusion criteria:

* Presenting to the IVF clinic for IVF/ICSI treatment or routine semen analysis
* Semen sample must have a total sperm count of ≥1 million sperm/ml
* Availability of excess, leftover sperm after clinical treatment procedures
* Couples must have experienced infertility for at least one year and be undergoing fertility treatment
* Undergoing standard clinical treatment protocols (including embryo culture and, when applicable, PGTA) with routinely collected treatment outcome data
* Sufficient ovarian reserve and/or meeting the clinic's standard criteria for fertility treatment

Couple exclusion criteria:

* Known genetic disorders affecting fertility
* History of vasectomy or other irreversible sterilization procedures
* Current use of medications known to affect sperm parameters (e.g., exogenous androgens, chemotherapeutic agents, or other drugs specifically impacting spermatogenesis)
* Recent history of chemotherapy or radiation therapy
* Female age \>38 years old
* Known chromosomal abnormalities or genetic disorders that directly affect oocyte quality or embryo development
* Presence of severe uterine or pelvic pathology (e.g., significant uterine anomalies, advanced endometriosis)
* Documented ovarian failure or extremely diminished ovarian reserve as determined by AMH levels (AMH \>1 ng/mL, AFC ≥5)
* Use of medications or undergoing treatments that could significantly alter oocyte quality or embryogenesis (outside standard ART protocols).

Where it's running

  • Fakih IVF
    Abu Dhabi, United Arab Emirates
    Recruiting
  • Khalifa University
    Abu Dhabi, United Arab Emirates
    Active not recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.